Literature DB >> 19820758

[Short cold ischaemia time optimises transplant results for kidneys from expanded criteria donors].

E Gallego Valcarce1, A Ortega Cerrato, F Llamas Fuentes, J Masiá Mondéjar, G Martínez Fernández, E López Rubio, A López Montes, J Pérez Martinez, M Martínez Villaescusa, C Gómez Roldán.   

Abstract

INTRODUCTION: Outcome of renal transplant from expanded criteria donors (ECD) is usually inferior than those from standard criteria donors (SCD) and may be improved decreasing cold ischemia time (CIT) and minimizing preservation injury. We compare the results obtained with CIT <15 hours in kidney transplants from ECD vs SCD. SUBJECTS AND METHODS: Prospective, single center study of kidney transplants performed since June 2003 to December 2007. Minimum follow-up period was 12 months. Data of donors, receptors and transplant outcome from ECD and SCD are compared.
RESULTS: CIT (mean +/- SD) was 9.3+/-2.5 hours in transplants from ECD (n=24) and 8.3+/-3.3 hours in those from SCD (N=50), p=0.18. We did not find significant differences among recipients of grafts from ECD and those from SCD regarding: primary non-function (4.2% vs 2%, respectively), delayed graft function (16.7% vs 10%), surgical complications (25% vs 16%) or acute rejection episodes (8.3% vs 2%). Glomerular filtration rate at one year follow-up was 65.8+/-14.9 ml/min in ECD recipients and 49.4+/-12.5 ml/min (p<0.0001). One year graft survival was 95.8% in ECD recipients and 94% in SCD recipients (p=0.75).
CONCLUSIONS: Short CIT in kidney transplant from ECD leads to similar outcome than that obtained from SCD, although renal function is inferior in ECD grafts.

Entities:  

Mesh:

Year:  2009        PMID: 19820758     DOI: 10.3265/Nefrologia.2009.29.5.5524.en.full

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  1 in total

1.  There is no need to stent the ureterovesical anastomosis in live renal transplants.

Authors:  Shanmugasundaram Rajaian; Santosh Kumar
Journal:  Indian J Urol       Date:  2010-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.